Influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumab.
Asia Pac J Clin Oncol
; 20(1): 16-24, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-36855021
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
/
Antibodies, Monoclonal
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
Asia Pac J Clin Oncol
Journal subject:
NEOPLASIAS
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: